Sign in

CIK 0001714899

  • Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
463872213
Phone
+1 650-866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Grant or award Director acquired 4,216 shares (grant or award)
  2. 4 Grant or award Director acquired 4,216 shares (grant or award)
  3. 4 Grant or award Director acquired 4,216 shares (grant or award)
  4. 4 Grant or award Director acquired 4,216 shares (grant or award)
  5. 4 Grant or award Director acquired 4,216 shares (grant or award)
  6. 4 Grant or award Director acquired 4,216 shares (grant or award)
  7. 4 Open-market sale COFO and Secretary sold 10,000 shares at an average $28.60 ($286,044)
  8. 4 Open-market sale President and CEO sold 25,000 shares at an average $25.15 ($628,720)
  9. 4 Open-market sale COFO and Secretary sold 10,000 shares at $25.04 ($250,400)
  10. 4 Open-market sale Chief Medical Officer sold 1,476 shares at $29.40 ($43,394)
  11. 4 Open-market sale Director sold 2,119 shares at $30.10 ($63,782)
  12. 4 Open-market sale COFO and Secretary sold 3,497 shares at $30.09 ($105,225)
  13. 4 Open-market sale President and CEO sold 33,815 shares at an average $30.08 ($1,017,243)
  14. 4 Open-market sale Chief Medical Officer sold 3,366 shares at an average $30.03 ($101,071)
  15. 4 Open-market sale President and CEO sold 28,433 shares at an average $29.28 ($832,515)
  16. 4 Open-market sale Chief Medical Officer sold 1,521 shares at $30.88 ($46,968)
  17. 4 Open-market sale COFO and Secretary sold 1,521 shares at $30.89 ($46,984)
  18. 4 Open-market sale Director sold 1,377 shares at $30.88 ($42,522)
  19. 4 Open-market sale COFO and Secretary sold 10,000 shares at an average $29.53 ($295,339)
  20. 4 Open-market sale Chief Medical Officer sold 1,459 shares at $28.48 ($41,552)

Page 7 of 22 · 436 filings